Abstract
Summary: The neurometabolic disorder l‐2‐hydroxyglutaric aciduria is caused by mutations in a gene present on chromosome 14q22.1 and encoding l‐2‐hydroxyglutarate dehydrogenase. This FAD‐linked mitochondrial enzyme catalyses the irreversible conversion of l‐2‐hydroxyglutarate to alpha‐ketoglutarate. The formation of l‐2‐hydroxyglutarate results from a side‐activity of mitochondrial l‐malate dehydrogenase, the enzyme that interconverts oxaloacetate and l‐malate, but which also catalyses, very slowly, the NADH‐dependent conversion of alpha‐ketoglutarate to l‐2‐hydroxyglutarate. l‐2‐Hydroxyglutarate has no known physiological function in eukaryotes and most prokaryotes. Its accumulation is toxic to the mammalian brain, causing a leukoencephalopathy and increasing the susceptibility to develop tumours. l‐2‐Hydroxyglutaric aciduria appears to be the first disease of ‘metabolite repair’.

This publication has 50 references indexed in Scilit: